Incyte expands agreement with Lilly

The companies will identify and select secreted molecules that are candidates for therapeutic protein development under an expanded 1996 agreement. LLY also will obtain options to license multiple therapeutic protein patents from INCY. In 1996, LLY received access to INCY's LifeSeq gene sequence expression database, the LifeSeq FL database of full-length genes, and the PathoSeq microbial database (see BioCentury, Dec. 23, 1996). ...